Continue to content

Hematology trials in Belgium

Anyone can find, through the platforms below, open trials for hematological patients in Belgium, which are approved by the Federal Agency for Medicines and Health Products (FAMHP) and that have not yet been completed. These databases enable both healthcare professionals and patients to consult the recruitment criteria for clinical trials in Belgium.

Doctors can use the information from the clinical trials database to guide patients wishing to participate in a clinical trial to help find one that is most appropriate for them.

What's a clinical trial?

A medicine that is available to patients is the result of a long and complex process, whether it is developed in an academic research centre or in a pharmaceutical company. At the end of this process, approximately one medicine in ten tested receives a marketing authorisation.

The development of a medicine involves several steps. In each one of them, specific questions are asked and specific aspects are assessed. Before a medicine is marketed, it is analysed through non-clinical or preclinical research to determine its mechanism of action and its toxicity. It is then tested on animals as well. If the balance between the benefits and the risks of the medicinal product turns out positive, after all these non-clinical studies have been conducted, clinical trials can be carried out on human volunteers.*

Therefore, the aim of a clinical trial is to improve medicine. More specifically, clinical trials aim to find and test new treatments for certain conditions or diseases before they even hit the market.

Before embarking on such research or study, it is best to be well informed by your general physician as he knows best what is and is not possible for you.

*Source: AFMPS website